About this app
"Urology RENAL Nephrometry Score - Kidney Cancer" is an app to help medical practitioner to quantifies the salient characteristics of kidney tumor in an objective and reproducible manner. In "Urology RENAL Nephrometry Score - Kidney Cancer" app, the total nephrometry scores will be counted and classified. Masses with score 4-6 were considered low complexity for resection, 7-9 were considered moderate complexity, and 10-12 were considered high complexity. There are several features of "Urology RENAL Nephrometry Score - Kidney Cancer", namely: - Simple and very easy to use for urologist. - Precise calculation of RENAL nephrometry score. - Very useful before making surgical decision for kidney tumor. - It is totally free. Download now! RENAL Nephrometry scoring system is based on the 5 most reproducible features that characterize the anatomy of a solid kidney tumor: (R)adius, (E)xophytic/endophytic properties of the tumor, (N)earness of the tumor to the collecting system or renal sinus, (A)nterior (a)/posterior (p) descriptor and the (L)ocation relative to the polar line. All components except for the (A) descriptor are scored on a 1, 2, or 3-point scale. The (A) describes the principal mass location to the coronal plane of the kidney. Higher complexity is associated with higher major complication rates if partial nephrectomy is performed for those tumor. We hope that "Urology RENAL Nephrometry Score - Kidney Cancer" app will help medical practitioner, especially urologist for surgical decision-making of the kidney tumor.
Latest release
What’s New
Fix several bugs and improve performance
Audience growth
Ratings growth
Baseline captured. Growth appears after the crawler observes a changed rating count.
Momentum comes from crawler snapshots for the tracked storefront. “Viral growth signal” means unusually fast recent rating gains; it is an indicator, not download data.
Price tracking
Price intelligence
First snapshot captured. The trend line starts after the next crawler price observation.
- First observed Sep 8, 2026 · 12:14 AM Free